The Faculty of Medicine, Chulalongkorn University, the second oldest medical school in Thailand, was established in 1947 in accordance with the wishes of King Ananda Mahidol to educate a sufficient number of medical doctors to satisfy the public's demands.

During the past decade, Chula Clinical Research Center conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Chula Clinical Research Center" #1 collaborator was "Academic Clinical Research Office (ACRO), Faculty of Medicine, Khon Kaen University" with 1 trials as a collaborator, "BioNet-Asia" with 1 trials as a collaborator, "Chula Clinical Research Center (Chula CRC), Faculty of Medicine, Chulalongkorn University" with 1 trials as a collaborator and "National Vaccine Institute, Thailand" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Chula Clinical Research Center" are "Assess Which Dose is Appropriate to Use" (1 trials), "Coronavirus" (1 trials), "Immune Response of 25 ug of ChulaCov19-BNA159 mRNA Vaccine" (1 trials), "Immune Response of 50 ug of ChulaCov19-BNA159 mRNA Vaccine" (1 trials) and "Kidney Stone" (1 trials). Many other conditions were trialed in "Chula Clinical Research Center" in a lesser frequency.

Most popular intervention types in "Chula Clinical Research Center" are "Biological" (2 trials), "Dietary Supplement" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Baiya SARS-CoV-2 Vax 1" (1 trials), "Bevacizumab-EU" (1 trials), "Bevacizumab-Pfizer" (1 trials), "Carboplatin" (1 trials) and "ChulaCov19 BNA159 mRNA vaccine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Chula Clinical Research Center" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Chula Clinical Research Center". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Chula Clinical Research Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Chula Clinical Research Center, 3 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".